Nanostructured lipid carriers as a potential vehicle for Carvedilol delivery: Application of factorial design approach

Artif Cells Nanomed Biotechnol. 2016;44(1):12-9. doi: 10.3109/21691401.2014.909820. Epub 2014 May 28.

Abstract

Present invention relates to design of nanostructured lipid carriers (NLC) to augment oral bioavailability of Carvedilol (CAR). In this attempt, formulations of CAR-NLCs were prepared with glyceryl-monostearate (GMS) as a lipid, poloxamer 188 as a surfactant and tween 80 as a co-surfactant using high pressure homogenizer by 2(3) factorial design approach. Formed CAR-NLCs were assessed for various performance parameters. Accelerated stability studies demonstrated negligible change in particle size and entrapment efficiency, after storage at specified time up to 3 months. The promising findings in this investigation suggest the practicability of these systems for enhancement of bioavailability of drugs like CAR.

Keywords: design expert; high pressure homogenization; nanostructured lipid carrier.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antihypertensive Agents / chemistry*
  • Carbazoles / chemistry*
  • Carvedilol
  • Drug Carriers / chemistry*
  • Drug Compounding / methods
  • Drug Liberation
  • Drug Stability
  • Factor Analysis, Statistical
  • Glycerides / chemistry
  • Humans
  • Nanostructures / chemistry*
  • Nanostructures / ultrastructure
  • Particle Size
  • Poloxamer / chemistry
  • Polysorbates / chemistry
  • Pressure
  • Propanolamines / chemistry*

Substances

  • Antihypertensive Agents
  • Carbazoles
  • Drug Carriers
  • Glycerides
  • Polysorbates
  • Propanolamines
  • Carvedilol
  • Poloxamer
  • glyceryl monostearate